Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | -2.47% | -6.16% | -12.57% |
Business Summary
Number of employees: 13
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Real Estate
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -31.95% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Israel
53.0
%
| 0 | 7.1 % | 0 | 53.0 % | +409.90% |
United States
47.0
%
| 0 | 92.9 % | 0 | 47.0 % | -65.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
William Conkling
CEO | Chief Executive Officer | 53 | 14/03/21 |
David Polinsky
DFI | Director of Finance/CFO | 53 | 30/11/17 |
Howard Jonas
CHM | Chairman | 68 | 16/08/17 |
Gus Kodersha
CTO | Chief Tech/Sci/R&D Officer | - | 16/08/21 |
John Goldberg
CTO | Chief Tech/Sci/R&D Officer | 51 | 11-19 |
Barbara Ryan
IRC | Investor Relations Contact | 64 | - |
Joyce Mason
SEC | Corporate Secretary | 65 | 30/06/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Jonas
CHM | Chairman | 68 | 16/08/17 |
Director/Board Member | 80 | 25/03/18 | |
Michael Weiss
BRD | Director/Board Member | 73 | 28/02/18 |
Mark McCamish
BRD | Director/Board Member | 72 | 13/06/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 787,163 | 0 | 0 | 76.32 % |
Stock B | 0 | 23,984,061 | 18,906,403 ( 78.83 %) | 186,785 ( 0.7788 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CYCLO THERAPEUTICS, INC. 31.45% | 9,029,940 | 31.45% | 12,551,617 $ |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-12.57% | 39.83M | |
+40.41% | 29.49B | |
-11.60% | 27.43B | |
+7.86% | 27.14B | |
+20.90% | 26.59B | |
+49.25% | 23.87B | |
+13.23% | 21.03B | |
-1.52% | 19.01B | |
+28.90% | 16.66B | |
-13.27% | 15.27B |
- Stock Market
- Equities
- RFL Stock
- Company Rafael Holdings, Inc.